AlphAIAlphAI — Financial news for AI agents
investing.comOCT 232 min read$MOH

Mizuho reiterates Molina Healthcare stock rating after Q3 beat

Mizuho reiterated an Outperform rating and $255.00 price target on Molina Healthcare (MOH) after its Q3 2026 earnings beat. The company reported adjusted EPS of $0.89, exceeding estimates of $0.74, driven by premium revenue. MOH stock has gained 24% over six months, trading at $216.64. The company maintained its full-year guidance but noted pressures from Florida contracts and Medicare Advantage losses.

Original reporting
investing.com
Published Oct 23, 2026, 8:56 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 9:23 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$MOH
Bullish
high confidence
Mentioned
$MOH
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$MOHBullishMed
01

Why it matters

The earnings beat and rating reaffirmation could drive short‑term buying interest.

02

Market read

Earnings beat and upgraded target provide a fresh catalyst for MOH trading.

03

What to watch

Potential margin pressure from Medicaid rates and upcoming 2027 premium rate changes.

Relevance 8/10Novelty 8/10Timing: post-market today

Background

Molina Healthcare posted Q3 2026 results, beating EPS expectations and maintaining guidance, prompting analyst rating reaffirmations.

Company-level read

Ticker impact

$MOHBullishHigh confidence
Context

Mizuho reiterated Outperform and raised price target to $255 after Molina Healthcare reported Q3 earnings beat with EPS $0.89 vs $0.74 estimate.

Expected impact

likely upward pressure as investors price in the earnings beat and higher target.

Evidence & confidence

The beat and rating upgrade are fresh data that can move the stock in the near term.

Market effects

Sector

Strong earnings may lift the broader managed‑care and health‑insurance sector.

Regional

U.S. health‑care stocks could see modest gains.

Global

Limited to U.S. markets; no direct global effect.

Counterpoint

What could challenge this read

Some investors may worry about cost pressures from the Florida contract and Medicare Advantage losses.

Key entities

  • analyst
    Mizuho

    Reiterated Outperform rating and raised price target.

Read at source← All news

StoryMolina Healthcare posts Q3 2026 earnings beat and reaffirms full‑year guidance

Also covered by

4 outlets

Related articles

OCT 23
$MOHMedAI 8/10

MOH Q3 deep dive: Medicaid margin stabilization and rate cycle drive cautious optimism

MOH reported Q3 revenue of $11.08B, beating estimates, with adjusted EPS of $0.89, also above expectations. Management maintained full-year EPS guidance. Medicaid margins stabilized due to rate increases, but membership declined. The company launched a $6B Florida CMS contract, expecting initial losses before break-even. Medicare duals performed well, while Marketplace business is being reduced.

finance.yahoo.com3 min
OCT 22
$MOHMed

Molina Healthcare Inc (MOH) (Q3 2026) Earnings Call Highlights: Reaffirmed Guidance

Molina Healthcare (MOH) reported Q3 2026 adjusted pre-tax margin of 0.6% and reaffirmed guidance. Medicaid cost trend rose to 5.5%, and new contracts in Georgia/Texas were delayed. Marketplace and Medicare MAPD segments are expected to lose $0.75 and $1 per share, respectively, in 2026. CEO Joe Zubretsky and CFO Mark Keim discussed Medicaid MLR improvements, Florida CMS contract, and enrollment declines.

finance.yahoo.com3 min
OCT 22
$MOHHighAI 8/10

Molina Healthcare Q3 Earnings Call Highlights

Molina Healthcare (MOH) expects its legacy Medicaid business to achieve a 1.6% pretax margin in 2026, with a 6% rate increase projected for 2027. The company anticipates a 6% membership decline in 2027 due to federal work requirements. Its Florida CMS contract, started in Q3, is expected to create a $1.50-per-share earnings drag in 2026. Molina's 2027 premium revenue is projected at $45 billion, down from $46.5 billion. The company's Medicare and Marketplace segments show mixed performance.

finance.yahoo.com3 min
OCT 22
$MOHHighAI 8/10

Molina Healthcare (MOH) Q3 2026 Earnings Call Transcript

Molina Healthcare (MOH) reported Q3 2026 adjusted EPS of $0.89B on $10.5B premium revenue, with a 92.9% MCR. Full-year 2026 guidance remains $42B in premium revenue and at least $5.25 EPS. 2027 premium revenue is expected to be at least $45B, with known rate increases averaging 6% and medical cost trend projected at 5.5%-6%. The company reaffirmed its Medicaid and Medicare strategies, including exiting the MAPD business and reducing Marketplace footprint.

finance.yahoo.com3 min